Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Denmark | 72 | 2024 | 778 | 4.880 |
Why?
|
Mendelian Randomization Analysis | 23 | 2024 | 1036 | 4.220 |
Why?
|
Myeloproliferative Disorders | 16 | 2024 | 614 | 3.330 |
Why?
|
Transferrin | 13 | 2024 | 285 | 3.080 |
Why?
|
Hemochromatosis | 13 | 2024 | 176 | 3.000 |
Why?
|
Hypothyroidism | 12 | 2024 | 670 | 2.910 |
Why?
|
Thyroxine | 14 | 2024 | 666 | 2.640 |
Why?
|
Ferritins | 10 | 2024 | 601 | 2.490 |
Why?
|
Milk | 6 | 2018 | 445 | 2.290 |
Why?
|
Lactase | 7 | 2018 | 72 | 2.200 |
Why?
|
Thrombocythemia, Essential | 6 | 2024 | 114 | 2.160 |
Why?
|
Polycythemia Vera | 9 | 2024 | 161 | 2.110 |
Why?
|
Hyperthyroidism | 7 | 2024 | 295 | 2.100 |
Why?
|
Thyroid Gland | 10 | 2024 | 1172 | 2.070 |
Why?
|
Calreticulin | 8 | 2024 | 115 | 2.030 |
Why?
|
Hidradenitis Suppurativa | 14 | 2022 | 179 | 1.850 |
Why?
|
Thyrotropin | 14 | 2024 | 834 | 1.770 |
Why?
|
Janus Kinase 2 | 14 | 2024 | 561 | 1.730 |
Why?
|
Iodide Peroxidase | 7 | 2024 | 295 | 1.540 |
Why?
|
Iron Overload | 8 | 2023 | 241 | 1.420 |
Why?
|
Primary Myelofibrosis | 4 | 2024 | 209 | 1.250 |
Why?
|
Suburban Population | 7 | 2023 | 54 | 1.240 |
Why?
|
Thyroid Hormones | 3 | 2020 | 407 | 1.110 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2024 | 12242 | 1.090 |
Why?
|
Iron | 11 | 2024 | 1813 | 1.080 |
Why?
|
Psoriasis | 10 | 2022 | 947 | 1.000 |
Why?
|
Suburban Health | 4 | 2017 | 11 | 0.980 |
Why?
|
Diabetes Mellitus, Type 1 | 12 | 2024 | 3440 | 0.970 |
Why?
|
Autoantibodies | 6 | 2023 | 2131 | 0.930 |
Why?
|
Lactose Intolerance | 3 | 2018 | 28 | 0.870 |
Why?
|
Acne Vulgaris | 3 | 2018 | 351 | 0.860 |
Why?
|
Strabismus | 3 | 2022 | 317 | 0.850 |
Why?
|
Graves Ophthalmopathy | 2 | 2022 | 135 | 0.850 |
Why?
|
Dairy Products | 4 | 2019 | 490 | 0.830 |
Why?
|
Anemia, Pernicious | 1 | 2022 | 15 | 0.830 |
Why?
|
Wet Macular Degeneration | 1 | 2024 | 165 | 0.780 |
Why?
|
Guanosine | 5 | 2024 | 43 | 0.740 |
Why?
|
Mortality | 5 | 2024 | 2917 | 0.740 |
Why?
|
Oxidative Stress | 11 | 2024 | 3145 | 0.730 |
Why?
|
Electrocardiography | 15 | 2024 | 6410 | 0.710 |
Why?
|
Nucleosides | 1 | 2021 | 131 | 0.710 |
Why?
|
Genotype | 19 | 2024 | 13047 | 0.700 |
Why?
|
Kidney | 7 | 2023 | 7064 | 0.680 |
Why?
|
Birth Weight | 4 | 2021 | 2117 | 0.660 |
Why?
|
Bruch Membrane | 2 | 2016 | 65 | 0.650 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2021 | 191 | 0.650 |
Why?
|
Registries | 6 | 2024 | 8373 | 0.640 |
Why?
|
Retinal Drusen | 2 | 2016 | 78 | 0.630 |
Why?
|
Vaginal Birth after Cesarean | 1 | 2019 | 62 | 0.630 |
Why?
|
Goiter | 1 | 2019 | 87 | 0.630 |
Why?
|
Hemostasis | 1 | 2021 | 470 | 0.620 |
Why?
|
Middle Aged | 97 | 2024 | 223418 | 0.620 |
Why?
|
Allostasis | 3 | 2024 | 73 | 0.610 |
Why?
|
Cross-Sectional Studies | 41 | 2024 | 26351 | 0.610 |
Why?
|
Female | 120 | 2024 | 396943 | 0.610 |
Why?
|
Cataract | 1 | 2024 | 837 | 0.610 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2021 | 554 | 0.610 |
Why?
|
Humans | 177 | 2024 | 768451 | 0.610 |
Why?
|
Prediabetic State | 3 | 2020 | 548 | 0.600 |
Why?
|
Eye Diseases, Hereditary | 2 | 2016 | 122 | 0.600 |
Why?
|
Aged | 80 | 2024 | 171520 | 0.590 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2024 | 16029 | 0.590 |
Why?
|
Male | 113 | 2024 | 364781 | 0.590 |
Why?
|
Blood Cells | 1 | 2019 | 308 | 0.590 |
Why?
|
Erectile Dysfunction | 1 | 2021 | 445 | 0.570 |
Why?
|
Glomerular Filtration Rate | 4 | 2023 | 2226 | 0.570 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2021 | 363 | 0.570 |
Why?
|
Appendicitis | 1 | 2024 | 687 | 0.560 |
Why?
|
Macular Degeneration | 1 | 2024 | 1016 | 0.550 |
Why?
|
Abortion, Spontaneous | 2 | 2021 | 539 | 0.540 |
Why?
|
Maternal Age | 1 | 2019 | 809 | 0.540 |
Why?
|
Thyroid Function Tests | 4 | 2021 | 289 | 0.530 |
Why?
|
Adult | 85 | 2024 | 223542 | 0.530 |
Why?
|
Arrhythmias, Cardiac | 5 | 2023 | 2258 | 0.520 |
Why?
|
Genome-Wide Association Study | 16 | 2024 | 12774 | 0.510 |
Why?
|
Triiodothyronine | 6 | 2024 | 492 | 0.510 |
Why?
|
Aged, 80 and over | 37 | 2024 | 59680 | 0.500 |
Why?
|
Smoking | 5 | 2019 | 9099 | 0.490 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1797 | 0.490 |
Why?
|
Biological Specimen Banks | 4 | 2024 | 783 | 0.490 |
Why?
|
Arthritis, Psoriatic | 1 | 2017 | 220 | 0.480 |
Why?
|
Population Surveillance | 5 | 2019 | 2601 | 0.480 |
Why?
|
Spirometry | 1 | 2018 | 928 | 0.480 |
Why?
|
Inflammation | 10 | 2024 | 10865 | 0.470 |
Why?
|
RNA | 6 | 2024 | 2727 | 0.460 |
Why?
|
Risk Factors | 34 | 2024 | 74915 | 0.460 |
Why?
|
Hip Fractures | 3 | 2018 | 996 | 0.450 |
Why?
|
Depressive Disorder | 3 | 2022 | 3738 | 0.450 |
Why?
|
Iron, Dietary | 4 | 2023 | 149 | 0.450 |
Why?
|
Specimen Handling | 2 | 2016 | 709 | 0.450 |
Why?
|
beta-Thalassemia | 1 | 2016 | 236 | 0.440 |
Why?
|
Chemistry, Clinical | 3 | 2022 | 64 | 0.440 |
Why?
|
Educational Status | 3 | 2017 | 2519 | 0.430 |
Why?
|
Thyroidectomy | 1 | 2019 | 915 | 0.420 |
Why?
|
Genetic Predisposition to Disease | 13 | 2023 | 18048 | 0.420 |
Why?
|
Interferon-alpha | 5 | 2024 | 909 | 0.410 |
Why?
|
Laparoscopy | 1 | 2024 | 2056 | 0.400 |
Why?
|
Creatinine | 5 | 2023 | 1915 | 0.400 |
Why?
|
Metabolic Diseases | 1 | 2018 | 685 | 0.390 |
Why?
|
Prenatal Care | 1 | 2019 | 1159 | 0.390 |
Why?
|
Case-Control Studies | 25 | 2023 | 22293 | 0.390 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1561 | 0.390 |
Why?
|
Young Adult | 38 | 2024 | 60045 | 0.380 |
Why?
|
Atrial Fibrillation | 3 | 2019 | 5162 | 0.380 |
Why?
|
Goals | 1 | 2017 | 715 | 0.380 |
Why?
|
Self Report | 6 | 2024 | 3771 | 0.380 |
Why?
|
Long QT Syndrome | 1 | 2016 | 472 | 0.380 |
Why?
|
Kidney Diseases | 2 | 2020 | 2102 | 0.380 |
Why?
|
Social Class | 2 | 2017 | 2000 | 0.370 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5887 | 0.370 |
Why?
|
Maternal Exposure | 1 | 2018 | 1078 | 0.370 |
Why?
|
Th17 Cells | 1 | 2017 | 798 | 0.370 |
Why?
|
Mutation | 15 | 2024 | 30243 | 0.350 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 2139 | 0.350 |
Why?
|
Lymphocytes | 3 | 2024 | 2611 | 0.340 |
Why?
|
Albuminuria | 3 | 2023 | 658 | 0.340 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2742 | 0.340 |
Why?
|
Personal Satisfaction | 1 | 2014 | 648 | 0.340 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2018 | 857 | 0.330 |
Why?
|
Liver Diseases | 3 | 2024 | 1307 | 0.310 |
Why?
|
Hypertension | 7 | 2020 | 8611 | 0.310 |
Why?
|
Rural Population | 6 | 2020 | 2317 | 0.310 |
Why?
|
Biological Products | 1 | 2017 | 937 | 0.310 |
Why?
|
Antidepressive Agents | 3 | 2022 | 2913 | 0.300 |
Why?
|
Diabetes, Gestational | 1 | 2018 | 1259 | 0.300 |
Why?
|
Income | 1 | 2017 | 1878 | 0.300 |
Why?
|
Bone Density | 2 | 2018 | 3561 | 0.300 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15638 | 0.300 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1374 | 0.300 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2291 | 0.290 |
Why?
|
Rural Health | 2 | 2020 | 300 | 0.290 |
Why?
|
Phenotype | 3 | 2021 | 16712 | 0.280 |
Why?
|
Life Style | 2 | 2017 | 3929 | 0.280 |
Why?
|
Adipokines | 2 | 2019 | 309 | 0.280 |
Why?
|
Hydroxyurea | 3 | 2023 | 284 | 0.280 |
Why?
|
Polyethylene Glycols | 2 | 2024 | 1195 | 0.270 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3230 | 0.270 |
Why?
|
Heart Conduction System | 3 | 2022 | 1009 | 0.270 |
Why?
|
Health Surveys | 4 | 2018 | 4056 | 0.260 |
Why?
|
General Practice | 2 | 2017 | 100 | 0.260 |
Why?
|
Vision Screening | 2 | 2019 | 72 | 0.260 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1097 | 0.260 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2538 | 0.260 |
Why?
|
Deoxyguanosine | 3 | 2024 | 96 | 0.260 |
Why?
|
Prevalence | 13 | 2020 | 15880 | 0.250 |
Why?
|
Body Mass Index | 7 | 2022 | 13030 | 0.250 |
Why?
|
Urban Population | 1 | 2013 | 2047 | 0.250 |
Why?
|
Genetic Variation | 3 | 2019 | 6610 | 0.240 |
Why?
|
Gene Frequency | 3 | 2023 | 3615 | 0.240 |
Why?
|
Depression | 3 | 2018 | 8235 | 0.240 |
Why?
|
Age Factors | 11 | 2019 | 18478 | 0.240 |
Why?
|
Visually Impaired Persons | 2 | 2016 | 79 | 0.230 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7863 | 0.230 |
Why?
|
Neoplasms | 9 | 2023 | 22386 | 0.230 |
Why?
|
Antihypertensive Agents | 4 | 2017 | 2028 | 0.230 |
Why?
|
Homozygote | 3 | 2024 | 1779 | 0.230 |
Why?
|
Depressive Disorder, Major | 4 | 2021 | 4816 | 0.230 |
Why?
|
Overweight | 1 | 2015 | 2428 | 0.230 |
Why?
|
Netherlands | 3 | 2018 | 2274 | 0.220 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3253 | 0.220 |
Why?
|
Isocarboxazid | 1 | 2003 | 7 | 0.220 |
Why?
|
Obesity | 5 | 2022 | 13065 | 0.220 |
Why?
|
Somatotypes | 1 | 2023 | 41 | 0.210 |
Why?
|
Membrane Proteins | 6 | 2024 | 7895 | 0.210 |
Why?
|
Heart Rate | 6 | 2024 | 4218 | 0.210 |
Why?
|
Blood Pressure | 5 | 2020 | 8538 | 0.210 |
Why?
|
Disease Progression | 4 | 2022 | 13655 | 0.210 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39430 | 0.200 |
Why?
|
Blood Coagulation | 2 | 2021 | 1162 | 0.200 |
Why?
|
Asthma | 2 | 2023 | 6274 | 0.200 |
Why?
|
Myocardial Infarction | 5 | 2022 | 11515 | 0.200 |
Why?
|
Vascular Diseases | 2 | 2021 | 1162 | 0.200 |
Why?
|
Atrioventricular Node | 1 | 2022 | 180 | 0.190 |
Why?
|
Nitriles | 2 | 2024 | 984 | 0.190 |
Why?
|
Dementia, Vascular | 1 | 2022 | 125 | 0.190 |
Why?
|
Alleles | 5 | 2020 | 6890 | 0.190 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10358 | 0.190 |
Why?
|
DNA Damage | 4 | 2024 | 2461 | 0.190 |
Why?
|
Antithyroid Agents | 1 | 2021 | 72 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3412 | 0.180 |
Why?
|
Atrioventricular Block | 1 | 2023 | 141 | 0.180 |
Why?
|
Incidence | 6 | 2024 | 21552 | 0.180 |
Why?
|
Janus Kinase 1 | 1 | 2021 | 108 | 0.180 |
Why?
|
Platelet Activation | 1 | 2024 | 646 | 0.180 |
Why?
|
Interferons | 2 | 2022 | 714 | 0.180 |
Why?
|
Histocompatibility Antigens Class I | 5 | 2024 | 1362 | 0.180 |
Why?
|
Odds Ratio | 7 | 2019 | 9687 | 0.180 |
Why?
|
Appendectomy | 1 | 2024 | 442 | 0.180 |
Why?
|
Blood Coagulation Tests | 1 | 2021 | 271 | 0.170 |
Why?
|
Cholesterol, HDL | 5 | 2024 | 1820 | 0.170 |
Why?
|
Fibrinolysis | 1 | 2021 | 333 | 0.170 |
Why?
|
Fathers | 1 | 2023 | 377 | 0.170 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2021 | 276 | 0.170 |
Why?
|
Sleep | 1 | 2015 | 4796 | 0.170 |
Why?
|
Oxidation-Reduction | 4 | 2018 | 2232 | 0.170 |
Why?
|
Biomedical Research | 1 | 2015 | 3463 | 0.160 |
Why?
|
Prospective Studies | 16 | 2024 | 54914 | 0.160 |
Why?
|
Lung | 1 | 2018 | 10090 | 0.160 |
Why?
|
Megakaryocytes | 1 | 2024 | 575 | 0.160 |
Why?
|
Albumins | 1 | 2022 | 578 | 0.160 |
Why?
|
Blood Coagulation Factors | 1 | 2021 | 366 | 0.160 |
Why?
|
Proportional Hazards Models | 6 | 2024 | 12561 | 0.160 |
Why?
|
Erythrocyte Count | 1 | 2019 | 157 | 0.160 |
Why?
|
Pregnancy | 6 | 2021 | 30179 | 0.160 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2019 | 102 | 0.160 |
Why?
|
Erythropoiesis | 1 | 2022 | 694 | 0.150 |
Why?
|
Atrial Premature Complexes | 1 | 2018 | 17 | 0.150 |
Why?
|
Insulin-Secreting Cells | 2 | 2016 | 900 | 0.150 |
Why?
|
Mannose-Binding Lectin | 1 | 2019 | 145 | 0.150 |
Why?
|
Blood Platelets | 3 | 2024 | 2485 | 0.150 |
Why?
|
Cohort Studies | 9 | 2024 | 41797 | 0.150 |
Why?
|
Ankle Brachial Index | 1 | 2018 | 163 | 0.150 |
Why?
|
Homocysteine | 1 | 2021 | 637 | 0.150 |
Why?
|
Glaucoma, Open-Angle | 1 | 2024 | 742 | 0.150 |
Why?
|
Leukocyte Count | 2 | 2019 | 1604 | 0.150 |
Why?
|
Risk | 6 | 2024 | 9642 | 0.150 |
Why?
|
Neutrophils | 2 | 2024 | 3790 | 0.150 |
Why?
|
Kidney Function Tests | 1 | 2020 | 681 | 0.150 |
Why?
|
von Willebrand Factor | 1 | 2021 | 679 | 0.140 |
Why?
|
Risk Assessment | 8 | 2021 | 24311 | 0.140 |
Why?
|
Genetic Testing | 4 | 2022 | 3586 | 0.140 |
Why?
|
Recombinant Proteins | 2 | 2024 | 6527 | 0.140 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6551 | 0.140 |
Why?
|
Decompression, Surgical | 1 | 2022 | 612 | 0.140 |
Why?
|
Poverty Areas | 1 | 2018 | 265 | 0.140 |
Why?
|
Thyroid Diseases | 1 | 2020 | 388 | 0.140 |
Why?
|
Ventricular Premature Complexes | 1 | 2018 | 112 | 0.140 |
Why?
|
Tumor Escape | 1 | 2020 | 374 | 0.140 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 708 | 0.140 |
Why?
|
Islets of Langerhans | 1 | 2023 | 1349 | 0.140 |
Why?
|
Lymphocyte Count | 1 | 2019 | 793 | 0.130 |
Why?
|
Receptors, Transferrin | 1 | 2018 | 300 | 0.130 |
Why?
|
Pyrazoles | 2 | 2024 | 2024 | 0.130 |
Why?
|
Athletic Performance | 1 | 2017 | 113 | 0.130 |
Why?
|
Quality of Life | 3 | 2020 | 13497 | 0.130 |
Why?
|
Skin Diseases | 2 | 2016 | 1099 | 0.130 |
Why?
|
Stroke | 3 | 2022 | 9791 | 0.130 |
Why?
|
Comorbidity | 6 | 2023 | 10601 | 0.130 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2019 | 511 | 0.130 |
Why?
|
Superoxide Dismutase | 1 | 2019 | 596 | 0.130 |
Why?
|
Fertility | 1 | 2021 | 772 | 0.130 |
Why?
|
Drug Utilization | 2 | 2014 | 1192 | 0.130 |
Why?
|
Immunomodulation | 1 | 2020 | 550 | 0.130 |
Why?
|
Retrospective Studies | 10 | 2024 | 81834 | 0.130 |
Why?
|
Complement C3 | 1 | 2017 | 434 | 0.130 |
Why?
|
Magnesium | 1 | 2019 | 816 | 0.130 |
Why?
|
Models, Cardiovascular | 1 | 2021 | 986 | 0.130 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14766 | 0.120 |
Why?
|
Fever | 1 | 2003 | 1622 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2021 | 749 | 0.120 |
Why?
|
Interleukin-1 | 1 | 2019 | 1251 | 0.120 |
Why?
|
Vital Capacity | 1 | 2018 | 984 | 0.120 |
Why?
|
Zinc | 1 | 2019 | 677 | 0.120 |
Why?
|
Cholesterol, LDL | 4 | 2022 | 2396 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2024 | 1299 | 0.120 |
Why?
|
Physical Endurance | 1 | 2017 | 370 | 0.120 |
Why?
|
Potassium | 1 | 2019 | 1319 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2019 | 1744 | 0.120 |
Why?
|
Pyrimidines | 2 | 2024 | 3050 | 0.120 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3854 | 0.120 |
Why?
|
Mood Disorders | 1 | 2021 | 1128 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2170 | 0.120 |
Why?
|
Diet | 4 | 2019 | 8098 | 0.120 |
Why?
|
Heart Failure | 1 | 2018 | 11857 | 0.110 |
Why?
|
Cytokines | 2 | 2019 | 7449 | 0.110 |
Why?
|
Folic Acid | 1 | 2021 | 1336 | 0.110 |
Why?
|
Sex Factors | 6 | 2019 | 10647 | 0.110 |
Why?
|
5' Untranslated Regions | 1 | 2015 | 255 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2014 | 6035 | 0.110 |
Why?
|
Medicine | 1 | 2022 | 946 | 0.110 |
Why?
|
Waist Circumference | 1 | 2017 | 935 | 0.110 |
Why?
|
Urine | 1 | 2015 | 363 | 0.110 |
Why?
|
Estradiol | 1 | 2021 | 1949 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2016 | 395 | 0.110 |
Why?
|
Brain Ischemia | 1 | 2007 | 3038 | 0.110 |
Why?
|
Infant, Newborn, Diseases | 1 | 2019 | 592 | 0.110 |
Why?
|
Angina Pectoris | 1 | 2017 | 960 | 0.110 |
Why?
|
Area Under Curve | 1 | 2017 | 1640 | 0.110 |
Why?
|
Severity of Illness Index | 8 | 2019 | 15965 | 0.110 |
Why?
|
Gallstones | 1 | 2015 | 285 | 0.110 |
Why?
|
Random Allocation | 1 | 2017 | 2399 | 0.110 |
Why?
|
Physical Fitness | 1 | 2017 | 744 | 0.110 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1820 | 0.110 |
Why?
|
Infant, Newborn | 7 | 2024 | 26395 | 0.100 |
Why?
|
Demography | 1 | 2017 | 1643 | 0.100 |
Why?
|
Exons | 1 | 2019 | 2392 | 0.100 |
Why?
|
Age Distribution | 4 | 2014 | 2881 | 0.100 |
Why?
|
Epidemics | 1 | 2018 | 517 | 0.100 |
Why?
|
Genetics, Population | 1 | 2017 | 946 | 0.100 |
Why?
|
Amblyopia | 1 | 2014 | 152 | 0.100 |
Why?
|
Blood | 1 | 2015 | 597 | 0.100 |
Why?
|
Thrombophilia | 1 | 2015 | 306 | 0.100 |
Why?
|
Microcirculation | 1 | 2017 | 1282 | 0.100 |
Why?
|
Health Services Research | 1 | 2020 | 1815 | 0.100 |
Why?
|
Self Care | 1 | 2017 | 798 | 0.100 |
Why?
|
Quality Control | 1 | 2015 | 835 | 0.100 |
Why?
|
Genetic Linkage | 1 | 2017 | 2342 | 0.100 |
Why?
|
Photography | 1 | 2015 | 537 | 0.100 |
Why?
|
Hemoglobins | 1 | 2018 | 1532 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2019 | 1375 | 0.100 |
Why?
|
Autoimmunity | 2 | 2023 | 1361 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 681 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2007 | 4362 | 0.100 |
Why?
|
Animals | 10 | 2021 | 169418 | 0.100 |
Why?
|
Mental Disorders | 2 | 2024 | 6879 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2013 | 425 | 0.090 |
Why?
|
Dietary Fats | 1 | 2019 | 2003 | 0.090 |
Why?
|
Research Design | 3 | 2017 | 6217 | 0.090 |
Why?
|
Sports | 1 | 2017 | 709 | 0.090 |
Why?
|
Spinal Fractures | 1 | 2018 | 712 | 0.090 |
Why?
|
Coronary Circulation | 1 | 2017 | 1617 | 0.090 |
Why?
|
Triglycerides | 2 | 2022 | 2465 | 0.090 |
Why?
|
Personality Inventory | 1 | 2014 | 1019 | 0.090 |
Why?
|
Adolescent | 10 | 2024 | 89168 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1960 | 0.090 |
Why?
|
Health Status | 1 | 2024 | 4096 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3615 | 0.090 |
Why?
|
Fluorescein Angiography | 1 | 2016 | 1086 | 0.090 |
Why?
|
Saliva | 1 | 2015 | 854 | 0.090 |
Why?
|
Length of Stay | 1 | 2024 | 6521 | 0.090 |
Why?
|
Testosterone | 1 | 2021 | 2493 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 972 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 2032 | 0.080 |
Why?
|
Nutritional Status | 1 | 2018 | 1623 | 0.080 |
Why?
|
ROC Curve | 1 | 2017 | 3624 | 0.080 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8721 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1816 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 764 | 0.080 |
Why?
|
Metalloendopeptidases | 2 | 2002 | 389 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2362 | 0.080 |
Why?
|
Anthropometry | 1 | 2013 | 1343 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2959 | 0.080 |
Why?
|
Lumbar Vertebrae | 1 | 2018 | 1885 | 0.080 |
Why?
|
Vision Disorders | 1 | 2016 | 1092 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2014 | 925 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6537 | 0.080 |
Why?
|
Lipids | 1 | 2019 | 3346 | 0.080 |
Why?
|
Insulin | 3 | 2019 | 6606 | 0.080 |
Why?
|
Leukocytes | 1 | 2016 | 2030 | 0.070 |
Why?
|
Dietary Supplements | 2 | 2018 | 3445 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1905 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2238 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1439 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2024 | 14728 | 0.070 |
Why?
|
Physical Examination | 1 | 2013 | 1262 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2020 | 12096 | 0.070 |
Why?
|
Dermatitis, Atopic | 1 | 2014 | 734 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 8051 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15460 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2018 | 1299 | 0.070 |
Why?
|
Body Composition | 1 | 2015 | 2455 | 0.070 |
Why?
|
Calcium | 1 | 2019 | 5793 | 0.060 |
Why?
|
Anemia | 1 | 2015 | 1521 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.060 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 591 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3590 | 0.060 |
Why?
|
Pharmacogenetics | 1 | 2009 | 677 | 0.060 |
Why?
|
Insulin Resistance | 2 | 2016 | 3974 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4451 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2017 | 3202 | 0.060 |
Why?
|
Endpoint Determination | 1 | 2007 | 591 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5709 | 0.060 |
Why?
|
Retina | 1 | 2015 | 2663 | 0.060 |
Why?
|
Hydrocortisone | 2 | 2022 | 1836 | 0.060 |
Why?
|
Hospitals | 2 | 2015 | 3906 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3111 | 0.060 |
Why?
|
Stroke Volume | 1 | 2018 | 5620 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3708 | 0.060 |
Why?
|
Child | 6 | 2024 | 80863 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2722 | 0.050 |
Why?
|
Mass Screening | 1 | 2019 | 5455 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2260 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2005 | 473 | 0.050 |
Why?
|
Heterozygote | 2 | 2007 | 2792 | 0.050 |
Why?
|
Estrogen Receptor alpha | 1 | 2007 | 582 | 0.050 |
Why?
|
Colon | 2 | 2002 | 1804 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 30028 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2018 | 3431 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 1884 | 0.050 |
Why?
|
Reference Values | 3 | 2021 | 4941 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2021 | 2932 | 0.050 |
Why?
|
Defense Mechanisms | 1 | 2022 | 180 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4861 | 0.050 |
Why?
|
Sex Determination Analysis | 1 | 2021 | 46 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15880 | 0.050 |
Why?
|
Cities | 1 | 2024 | 546 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10273 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3682 | 0.050 |
Why?
|
Elastin | 1 | 2022 | 299 | 0.050 |
Why?
|
Histamine | 1 | 2022 | 500 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 402 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2007 | 879 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4052 | 0.040 |
Why?
|
Family Health | 1 | 2005 | 1256 | 0.040 |
Why?
|
Heart Diseases | 2 | 2024 | 2816 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2016 | 4713 | 0.040 |
Why?
|
Intestinal Mucosa | 2 | 2002 | 3048 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2014 | 6242 | 0.040 |
Why?
|
Privacy | 1 | 2021 | 233 | 0.040 |
Why?
|
Anesthesia, Local | 1 | 2021 | 278 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2019 | 89 | 0.040 |
Why?
|
DNA | 2 | 2023 | 7213 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2022 | 658 | 0.040 |
Why?
|
Tibial Arteries | 1 | 2018 | 60 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4120 | 0.040 |
Why?
|
Laboratories | 1 | 2022 | 463 | 0.040 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2021 | 354 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2022 | 991 | 0.040 |
Why?
|
Genomic Instability | 1 | 2022 | 714 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1126 | 0.040 |
Why?
|
Oculomotor Muscles | 1 | 2021 | 405 | 0.040 |
Why?
|
Competitive Behavior | 1 | 2017 | 78 | 0.030 |
Why?
|
Brachial Artery | 1 | 2018 | 373 | 0.030 |
Why?
|
Cicatrix | 1 | 2022 | 799 | 0.030 |
Why?
|
Water Supply | 1 | 2017 | 204 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 712 | 0.030 |
Why?
|
Infant | 3 | 2024 | 36497 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1999 | 753 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2019 | 3080 | 0.030 |
Why?
|
Visual Acuity | 2 | 2016 | 2714 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 875 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 828 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 65409 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 2015 | 204 | 0.030 |
Why?
|
Neonatal Screening | 1 | 2019 | 618 | 0.030 |
Why?
|
Autopsy | 1 | 2018 | 1013 | 0.030 |
Why?
|
Suppuration | 1 | 2014 | 61 | 0.030 |
Why?
|
Unemployment | 1 | 2016 | 210 | 0.030 |
Why?
|
Teaching | 1 | 2022 | 1174 | 0.030 |
Why?
|
Antioxidants | 1 | 2022 | 1678 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1568 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2003 | 1409 | 0.030 |
Why?
|
Hand Dermatoses | 1 | 2014 | 62 | 0.030 |
Why?
|
Bilirubin | 1 | 2015 | 439 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2015 | 560 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4362 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2146 | 0.030 |
Why?
|
Calcinosis | 1 | 2022 | 1485 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2015 | 382 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13324 | 0.030 |
Why?
|
Family Characteristics | 1 | 2018 | 1002 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2526 | 0.030 |
Why?
|
China | 1 | 2019 | 2398 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 806 | 0.030 |
Why?
|
Microvessels | 1 | 2017 | 586 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 605 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2014 | 299 | 0.030 |
Why?
|
Immunity | 1 | 2019 | 1002 | 0.030 |
Why?
|
Pruritus | 1 | 2016 | 380 | 0.030 |
Why?
|
Chronic Disease | 2 | 2020 | 9382 | 0.030 |
Why?
|
Bipolar Disorder | 2 | 2021 | 5124 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2015 | 865 | 0.030 |
Why?
|
Platelet Count | 1 | 2015 | 786 | 0.030 |
Why?
|
Serum Albumin | 1 | 2015 | 676 | 0.030 |
Why?
|
Blood Glucose | 2 | 2019 | 6429 | 0.020 |
Why?
|
Aortic Valve | 1 | 2022 | 1968 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 2003 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2018 | 747 | 0.020 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 293 | 0.020 |
Why?
|
Obesity, Abdominal | 1 | 2014 | 375 | 0.020 |
Why?
|
Eczema | 1 | 2014 | 246 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2016 | 736 | 0.020 |
Why?
|
Central Nervous System | 1 | 2018 | 1348 | 0.020 |
Why?
|
Energy Intake | 1 | 2018 | 2141 | 0.020 |
Why?
|
Hypothalamus | 1 | 2016 | 1004 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1315 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5880 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2002 | 1930 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2847 | 0.020 |
Why?
|
Lower Extremity | 1 | 2018 | 1214 | 0.020 |
Why?
|
Crohn Disease | 1 | 2002 | 2293 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1357 | 0.020 |
Why?
|
ADAM Proteins | 2 | 2002 | 239 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6353 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2622 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2286 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3234 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42623 | 0.020 |
Why?
|
Fasting | 1 | 2014 | 1608 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4642 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2150 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6278 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2015 | 1183 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2014 | 874 | 0.020 |
Why?
|
Disease | 1 | 2012 | 673 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5096 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5909 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20231 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40271 | 0.020 |
Why?
|
Homeostasis | 1 | 2016 | 3351 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1999 | 2444 | 0.010 |
Why?
|
Aging | 1 | 2023 | 8761 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2008 | 21156 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2665 | 0.010 |
Why?
|
BRCA2 Protein | 1 | 2008 | 802 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 1152 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4520 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2007 | 682 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2591 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5940 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 2007 | 539 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8510 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 2008 | 1158 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14158 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2007 | 1209 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18388 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9526 | 0.010 |
Why?
|
Schizophrenia | 1 | 2018 | 6986 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22365 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13708 | 0.010 |
Why?
|
HLA Antigens | 1 | 2002 | 1338 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4249 | 0.010 |
Why?
|
Oligopeptides | 1 | 1999 | 1193 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4586 | 0.010 |
Why?
|
United States | 1 | 2019 | 73121 | 0.010 |
Why?
|
Colonoscopy | 1 | 1999 | 1412 | 0.010 |
Why?
|
Mice | 1 | 2017 | 82045 | 0.010 |
Why?
|
Cell Membrane | 1 | 1999 | 3664 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2002 | 11138 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13452 | 0.000 |
Why?
|
Biopsy | 1 | 1999 | 6816 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 17647 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1999 | 12813 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11206 | 0.000 |
Why?
|